BiomX (PHGE)
(Delayed Data from AMEX)
$0.99 USD
-0.05 (-4.55%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $0.99 0.00 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for BiomX Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 16 | 34 | 63 | 57 | 82 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 2 | 3 | 4 | 4 | 2 |
Total Current Assets | 18 | 37 | 67 | 61 | 85 |
Net Property & Equipment | 4 | 5 | 6 | 2 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 2 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 3 | 5 |
Total Assets | 25 | 46 | 78 | 70 | 92 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 3 | 2 | 3 |
Current Portion Long-Term Debt | 6 | 4 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 2 | 7 | 4 | 3 |
Total Current Liabilities | 11 | 8 | 11 | 7 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 5 | 11 | 14 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 2 | 0 | 1 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 22 | 24 | 30 | 13 | 8 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 166 | 158 | 156 | 130 | 127 |
Retained Earnings | -163 | -137 | -108 | -72 | -42 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3 | 21 | 48 | 57 | 84 |
Total Liabilities & Shareholder's Equity | 25 | 46 | 78 | 70 | 92 |
Total Common Equity | 3 | 21 | 48 | 57 | 84 |
Shares Outstanding | 4.60 | 3.00 | 2.80 | 2.30 | 2.20 |
Book Value Per Share | 0.67 | 7.01 | 16.98 | 24.99 | 38.39 |
Fiscal Year End for BiomX Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 33 | 44 | 16 | 23 | 31 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 2 | 3 | 2 | 2 | 3 |
Total Current Assets | 35 | 47 | 18 | 25 | 33 |
Net Property & Equipment | 7 | 7 | 4 | 4 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 16 | 16 | 0 | 0 | 0 |
Total Assets | 69 | 82 | 25 | 33 | 41 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 4 | 1 | 1 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 6 | 6 | 5 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 6 | 3 | 6 | 3 |
Total Current Liabilities | 7 | 11 | 11 | 13 | 12 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 5 | 7 | 8 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 25 | 2 | 2 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 41 | 59 | 22 | 25 | 25 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 32 | 32 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 171 | 171 | 166 | 166 | 165 |
Retained Earnings | -176 | -180 | -163 | -157 | -150 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 27 | 23 | 3 | 8 | 16 |
Total Liabilities & Shareholder's Equity | 69 | 82 | 25 | 33 | 41 |
Total Common Equity | -5 | -10 | 3 | 8 | 16 |
Shares Outstanding | 6.90 | 5.50 | 4.60 | 4.60 | 4.60 |
Book Value Per Share | -0.72 | -1.73 | 0.67 | 1.77 | 3.45 |